Dolby Laboratories Inc.

NYSE: DLB · Real-Time Price · USD
72.53
-1.19 (-1.61%)
At close: Aug 14, 2025, 3:59 PM
72.53
-0.01%
After-hours: Aug 14, 2025, 05:54 PM EDT

Dolby Laboratories Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 27, 2024 Jun 30, 2023 Sep 30, 2022 Sep 24, 2021
Revenue
1.27B 1.01B 1.25B 1.28B
Cost of Revenue
140.5M 117.01M 141.36M 130.03M
Gross Profit
1.13B 892.17M 1.11B 1.15B
Operating Income
258.33M 219.25M 206.6M 344.39M
Interest Income
n/a n/a 6.57M 3.49M
Pretax Income
312.48M 241.02M 215.28M 354.51M
Net Income
360.64M 191.47M 184.09M 310.23M
Selling & General & Admin
604.85M 455.36M 634.03M 556.83M
Research & Development
263.66M 201.1M 261.17M 253.64M
Other Expenses
n/a n/a 2.5M 7.11M
Operating Expenses
868.51M 656.46M 895.21M 810.47M
Interest Expense
34.08M n/a 394K 479K
Selling & Marketing Expenses
334.46M 263.49M 358.72M 332.67M
Cost & Expenses
1.01B 773.47M 1.04B 940.5M
Income Tax Expense
-48.16M -49.28M 31.38M 36.69M
Shares Outstanding (Basic)
95.54M 95.79M 99.99M 101.19M
Shares Outstanding (Diluted)
97.33M 97.59M 101.98M 104.62M
EPS (Basic)
3.77 2.00 1.84 3.07
EPS (Diluted)
3.71 1.96 1.81 2.97
EBITDA
258.33M 219.25M 329.9M 464.12M
EBIT
312.48M n/a 206.6M 344.39M
Depreciation & Amortization
87.33M 71.26M 123.3M 119.73M